NEWS TIPS & FEATURES

Breast Cancer Awareness Month: Ask Questions, Get Connected

What does breast cancer awareness month mean to you? We’d like to hear from you—join us on facebook, twitter, or CancerConnect and join the discussion. On October 10th  at 6pm EDT, we will have... [...]


Have a Question about Head and Neck Cancer? Ask the Expert!

CancerConnect and The Ohio State University Comprehensive Cancer Center- James Cancer Hospital and Solove Research Institute Will Present: Ask the Expert with Dr. Kang CancerConnect in collaboration with... [...]


The First CAR-T Therapy Heading to the FDA

Kite Pharma reported that its CAR-T therapy demonstrated a 39% response rate, including a 33% complete response rate, in patients with aggressive non Hodgkin lymphoma. The interim results from the phase... [...]


SBRT Offers Prostate Cancer Patients High Cancer Control and Low Toxicity in Fewer Treatments

High dose stereotactic body radiotherapy (SBRT) for men newly-diagnosed with low- or intermediate-risk prostate cancer results in shorter treatment times, low severe toxicity and excellent cancer control... [...]


Rituxan Improves Survival in Young Adults with Acute Lymphoblastic Leukemia

Acccording to results recently published in the New England Journal of Medicine, young adults with CD20-positive, Philadelphia chromosome  (PH)-negative acute lymphoblastic leukemia (ALL), experience... [...]


National Ovarian Cancer Coalition Launches CancerConnect Social Media Platform for Women with Ovarian Cancer

Austin TX/Sun Valley ID–The National Ovarian Cancer Coalition (NOCC) now offers a specialized social network for women with ovarian cancer. The NOCC CancerConnect Community offers these women a safe,... [...]


CDC Vaccine Information and Recommendations for the 2016/17 Influenza Season

With the start of a new school year and the approaching winter, it’s time to get informed about the most critical information regarding the 2016/17 influenza vaccines and CDC’s vaccination recommendations. The... [...]


140723-dang-026

Have a Question about Metastatic Breast Cancer? Ask the Expert!

Join us on October 10th! October 10th, 6:00-7:00 PM, EST Tune in here. Join us for a live Ask the Expert session with Memorial Sloan Kettering Cancer Center’s Chau T. Dang, MD. She will discuss advances... [...]


Cotellic®/Zelboraf® Combo: New Standard of Care for Melanoma

The treatment combination consisting of Cotellic® (cobimetinib) plus Zelboraf® (vemurafenib) improves overall survival for patients with advanced, BRAF (V600) mutation-positive melanoma. These confirmatory... [...]


« More News Tips & Features

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS